The trials will involve a total of 600 adults — half of whom have already received two doses of Moderna’s Covid-19 vaccine at least six months ago, and half of whom have received two doses plus the previously authorized booster dose.
The company also reported results on the efficacy against Omicron of the booster that has already been authorized. These data were obtained by studying the blood of 20 people who received the 50 microgram booster, half the amount of the first two injections. “Nonetheless, given the long-term threat demonstrated by Omicron’s immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study,” Bancel continued.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna begins trial of Omicron-specific vaccine booster — statementUS biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of COVID-19. Mode RNA.. Just be careful what you wish for. FactsNotFear 😷😷😷😷😷😷
Source: gmanews - 🏆 11. / 68 Read more »
Moderna vaccinates first participant in phase 2 trial of Omicron-specific booster as study finds that antibodies fall 6-fold over 6 monthsModerna announces that the first participant has been dosed in the company's Phase 2 clinical trial of a coronavirus vaccine booster shot that is specific to the Omicron variant.
Source: CNN Philippines - 🏆 13. / 63 Read more »
Pfizer-BioNTech begin Omicron vaccine trialThe company’s head of vaccine research Kathrin Jansen said in a statement that while current data showed that boosters against the original Covid strain continued to protect against severe outcomes with Omicron, the company was acting out of caution. Why would they spend so much money and time creating another one if the one they are using is supposedly working? This is nonsense.
Source: manilabulletin - 🏆 25. / 51 Read more »
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots — studyA third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac’s CoronaVac shot, a study has found.
Source: interaksyon - 🏆 24. / 51 Read more »
Two-thirds of Omicron cases in England reinfections — studyNearly two-thirds of people in England who tested positive for COVID-19 in January previously had the virus or suspected they had it, a large long-running infection survey revealed Wednesday.
Source: gmanews - 🏆 11. / 68 Read more »
PH logs 3 Omicron deaths; WHO: Strain risk very highThe Department of Health (DOH) on Wednesday reported three more fatalities among the Omicron variant COVID-19 cases in the Philippines, bringing the total to five. READ:
Source: MlaStandard - 🏆 20. / 55 Read more »